Denali Therapeutics DNLI
NASDAQ DNLI
$20.81 -0.17 (-0.81%)
At close: Sep 29, 2026 · 4:00 PM EDT

Denali Therapeutics (DNLI) Total Liabilities (2017 - 2026)

Updated

Denali Therapeutics (DNLI) reported Total Liabilities of $322.78 million for Q2 2026, up 131.9% from $139.19 million a year earlier but down 5.0% from the prior quarter.

Analysis

Denali Therapeutics (DNLI) Total Liabilities (2017 - 2026) Analysis & Trends

At the end of FY2025, Denali Therapeutics posted Total Liabilities of $131.09 million, down 9.3% from FY2024.

  • Total Liabilities has a five-year compound annual growth rate of -22.0% (FY2020 to FY2025).
  • By year, Total Liabilities came in at $144.5 million in FY2024 (+17.5%), $122.96 million in FY2023 (-70.6%), $417.81 million in FY2022 (-5.4%) and $441.87 million in FY2021 (-2.6%).
  • Five-year quarterly Total Liabilities spans a low of $115.51 million in Q2 2024 and a high of $442.64 million in Q1 2023.
  • Year over year, Total Liabilities gained in six of the last eight quarters, with growth averaging 39.7%.
  • The high point for year-over-year Total Liabilities in five years was Q3 2021 (growth of 133.1%); the low point was Q1 2024 (a decline of 71.6%).
  • Per Business Quant data, the three quarters before Q2 2026 came in at $339.93 million (Q1 2026), $131.09 million (Q4 2025) and $129.42 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 116.09 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 141.05 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 87.82 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 80.09 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 65.46 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 83.95 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 37.53 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 115.64 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 7.18 Bn
10 Denali Therapeutics 3.35 Bn 3.35 Bn 3.51 Mn 322.78 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 322.78 Mn
Mar 31, 2026 339.93 Mn
Dec 31, 2025 131.09 Mn
Sep 30, 2025 129.42 Mn
Jun 30, 2025 139.19 Mn
Mar 31, 2025 148.66 Mn
Dec 31, 2024 144.50 Mn
Sep 30, 2024 135.52 Mn
Jun 30, 2024 115.51 Mn
Mar 31, 2024 125.62 Mn
Dec 31, 2023 122.96 Mn
Sep 30, 2023 118.45 Mn
Jun 30, 2023 118.91 Mn
Mar 31, 2023 442.64 Mn
Dec 31, 2022 417.81 Mn
Sep 30, 2022 416.30 Mn
Jun 30, 2022 408.01 Mn
Mar 31, 2022 402.93 Mn
Dec 31, 2021 441.87 Mn
Sep 30, 2021 437.69 Mn
API Access

Denali Therapeutics Total Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-liabilities&ticker=DNLI&period=max&api_key=YOUR_API_KEY